Omkar Pharmachem Limited (BOM:532167)
6.21
+0.12 (1.97%)
At close: Nov 13, 2026
Omkar Pharmachem Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 3.71 | 4.65 | 5.4 | 5.4 | 5.4 | 5.4 | |
Revenue Growth | -31.37% | -13.89% | 0% | 0% | 0% | 100.00% |
Cost of Revenue | 2.25 | 2.09 | 1.61 | 1.61 | 1.39 | 1.75 |
Gross Profit | 1.46 | 2.56 | 3.79 | 3.8 | 4.01 | 3.65 |
Selling, General & Admin | 0.08 | 0.08 | 0.07 | 0.07 | 0.07 | 0.07 |
Other Operating Expenses | 0.86 | 0.83 | 0.83 | 0.9 | 0.84 | 0.9 |
Operating Expenses | 0.96 | 0.95 | 0.94 | 1.01 | 0.93 | 0.98 |
Operating Income | 0.5 | 1.62 | 2.85 | 2.78 | 3.08 | 2.67 |
Interest Expense | - | -0.02 | -0.17 | -0.29 | -0.47 | -0.56 |
Interest & Investment Income | 0.03 | 0.03 | 0.02 | 0.04 | 0.03 | - |
EBT Excluding Unusual Items | 0.53 | 1.63 | 2.7 | 2.53 | 2.65 | 2.11 |
Pretax Income | 0.53 | 1.63 | 2.7 | 2.53 | 2.65 | 2.11 |
Income Tax Expense | 0.15 | 0.41 | 0.69 | 0.64 | 0.67 | 0.27 |
Net Income | 0.38 | 1.22 | 2.01 | 1.89 | 1.98 | 1.83 |
Net Income to Common | 0.38 | 1.22 | 2.01 | 1.89 | 1.98 | 1.83 |
Net Income Growth | -72.89% | -39.37% | 6.24% | -4.40% | 8.03% | -17.30% |
Shares Outstanding (Basic) | 10 | 10 | 10 | 10 | 10 | 10 |
Shares Outstanding (Diluted) | 10 | 10 | 10 | 10 | 10 | 10 |
Shares Change | 0.44% | - | - | - | - | - |
EPS (Basic) | 0.04 | 0.12 | 0.20 | 0.19 | 0.20 | 0.18 |
EPS (Diluted) | 0.04 | 0.12 | 0.20 | 0.19 | 0.20 | 0.18 |
EPS Growth | -73.57% | -39.77% | 6.24% | -4.40% | 8.97% | -18.02% |
Additional Metrics
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | 1.05 | 2.29 | 2.4 | 2.86 | 2.76 | 1.96 |
Free Cash Flow Per Share | 0.10 | 0.23 | 0.24 | 0.28 | 0.27 | 0.19 |
Gross Margin | 39.29% | 55.14% | 70.24% | 70.28% | 74.28% | 67.57% |
Operating Margin | 13.44% | 34.82% | 52.76% | 51.56% | 57.07% | 49.41% |
Profit Margin | 10.31% | 26.19% | 37.20% | 35.02% | 36.63% | 33.91% |
Free Cash Flow Margin | 28.33% | 49.14% | 44.35% | 53.02% | 51.09% | 36.30% |
EBITDA | 0.52 | 1.65 | 2.9 | 2.83 | 3.11 | 2.69 |
EBITDA Margin | 13.98% | 35.44% | 53.63% | 52.43% | 57.57% | 49.76% |
D&A For EBITDA | 0.02 | 0.03 | 0.05 | 0.05 | 0.03 | 0.02 |
EBIT | 0.5 | 1.62 | 2.85 | 2.78 | 3.08 | 2.67 |
EBIT Margin | 13.44% | 34.82% | 52.76% | 51.56% | 57.07% | 49.41% |
Effective Tax Rate | 27.65% | 25.18% | 25.59% | 25.20% | 25.22% | 13.02% |
Revenue as Reported | 3.78 | 4.72 | 5.42 | 5.44 | 5.43 | 5.4 |
Advertising Expenses | - | 0.04 | 0.03 | 0.03 | 0.03 | 0.03 |